Loading...
  Loading...
Employer Quick Look

Cancer Care Northwest

(Public)  
Healthcare - Health Services
HQ: Spokane, WA   |   51 - 200 employees  |  
Overview
Cancer Care Northwest is the leading cancer care provider in the Inland Northwest. The practice is a physician-owned oncology network providing fully integrated leading-edge hematology/oncology care to patients in several state-of-the-art facilities. The staff is comprised of 18 physicians practicing in the areas of Medical, Radiation, Breast Surgery, Gynecologic and Surgical Oncology, in addition to two nurse practitioners, a physician assistant, lab assistants, Oncology Certified Nurses, RNs, LPNs, pharmacists, financial counselors, a clinical social worker and other support personnel. Services are provided from four convenient locations in the greater Spokane, Washington, area. For the convenience of cancer patients in outlying regions, Cancer Care Northwest also operates outreach clinics in Chewelah, Davenport, Moses Lake and Ritzville.

We are proud to be the first and only fully integrated cancer treatment center in the Inland Northwest, offering a complete range of diagnostic tests and treatments at our comprehensive cancer centers. CT scans, X-rays, chemotherapy treatment, therapeutic radiation, on-site laboratory, clinical research and support services from our licensed social worker are all available at our North and South clinic locations.

With over 20 year's of experience treating cancer patients, we recognize the importance of consolidating diagnostic tests, treatments and support programs under one roof, eliminating the need for patients to go from one facility to another for various services. Our patients lead busy lives with pressing time demands in addition to their cancer treatment, and we are committed to providing comprehensive, leading-edge treatment programs designed with patient comfort and convenience in mind.

Cancer Care Northwest is the only cancer treatment facility in the Inland Northwest with its own stationary Positron Emission Tomography (PET) Scanner, the very latest nuclear imaging technology used in the diagnosis and management of various cancers and other diseases. Our new PET Scanner brings a whole new level of diagnostic capabilities to our practice and we are pleased to offer our patients and the entire Spokane medical community access to this new and exciting technology.

We are part of US Oncology, the world 's largest health care network dedicated exclusively to cancer treatment and research, with over 800 cancer specialists caring for 15% of the nation's new cancer patients. Cancer Care Northwest, our patients, and the community gain a great deal from this affiliation. As part of the US Oncology network, we have access to the largest cancer research program in the country, providing our patients the very latest treatment options. We are electronically linked to all network physicians for instant access to important clinical trial information; this also gives us the ability to obtain hundreds of second opinions with the stroke of a computer key.

Research is an important part of our practice, and through our associations with national and regional clinical research groups, we are currently participating in over 125 clinical trials. During the last four years, we have placed over 400 patients on trials. These cutting-edge research studies advance our knowledge and cures for various types of cancers, as well as give our patients the very latest treatment options right here at home.

The physicians and staff at Cancer Care Northwest are committed to providing our patients vision, hope, passion and empowerment to help them successfully complete their healing journey and take an active role in their care.
Career Opportunities
Cancer Care Northwest (CCNW) Announces
Collaborative Autologous Stem Cell Transplant Program

CCNW, Deaconess Medical Center & Inland Northwest Blood Center Partner To Make Complex Procedure Available Locally


Cancer Care Northwest, the region’s largest cancer treatment and research facility, today announced the formation of a special collaborative stem cell transplant program to offer autologous stem cell transplants to patients throughout the region. Formed through the cooperation of several local medical facilities, the new Inland Northwest Autologous Stem Cell Transplant Program was developed so cancer patients in our area can receive their transplants locally rather than traveling to a larger city for treatment. Local treatment allows patients to have the much needed support of family and friends, in addition to saving patients the financial burden often created when they are treated out of town for an extended period of time.

In addition to Cancer Care Northwest, The Inland Northwest Blood Center (INBC) and Deaconess Medical Center play vital roles in the new program. The INBC collects the stem cells from the patient. The actual transplant procedure and immediate follow up care occur at Deaconess Medical Center in a dedicated facility where a highly skilled team of chemotherapy nurses closely supervises each patient’s daily care.
The director of the new program, Dr. Hakan Kaya, is a hematologist/medical oncologist at Cancer Care Northwest. Dr. Kaya has completed fellowship training in stem cell transplantation, and he has been performing the procedure for many years. He began offering autologous stem cell transplants at Cancer Care Northwest in August of 2005, and all of the patients who have undergone the procedure so far are doing extremely well. “This collaborative program is a significant development for the Spokane medical community," said Dr. Kaya. “We now have a high quality, well-established stem cell
transplant program in place, so there is no need for patients to face the burden of going to Seattle for this procedure,” he added.

In autologous transplants, patients serve as their own donor. Blood stem cells are harvested from the patient’s blood steam, frozen until needed, and then given back to the patient (transplanted) after very high doses of chemotherapy or radiation are administered to destroy the cancer cells. The re-infused stem cells then perform a “rescue mission,”rebuilding the patient’s white blood cells and platelets into healthy new cells in the bone marrow. Transplant patients are typically hospitalized for 2 to 3 weeks, and then must be closely monitored for several months. When the procedure is performed away from the patient’s home, living in another city for such an extended period of time can create a financial burden, as well as separating patients from the support of family and friends.
Contact
Ann Gower
Human Resource Coordinator
Cancer Care Northwest
(509)228-1303
Fax:(509) 252-9413